Skip to main content
Clinical Trials/NCT03668067
NCT03668067CompletedNot Applicable

Refractive and Strabismic Amblyopia Risk Factors Detected by Infrared Photoscreener and School Bus Skiascopy

Alaska Blind Child Discovery1 site in 1 country471 target enrollmentStarted: April 2, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
471
Locations
1
Primary Endpoint
Amblyopia Risk Factor (refractive error and/or strabismus)

Study Overview

Brief Summary

Pediatric eye patients receive infrared photoscreener screening and skiascopy as a part of routine examination to compare ability to detect amblyopia risk factors.

Detailed Description

Patients: Pediatric eye and adult strabismus patients undergoing routine examinations in a private ophthalmology practice.

Interventions: Infrared photoscreener / remote autorefractor such as 2 Winner (2WIN) ("Adaptica" - Padova, Italy) without and with infrared corneal reflex occluder. Child-friendly skiascopy before and after cycloplegic refraction.

Outcome: Amblyopia Risk Factors from comprehensive eye exam including refraction and strabismus.

Risk factors defined by American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2003 and 2013 guidelines.

**Please note that 2 Winner has nothing to do with actual device, but was required by the Clinical Trials Web entry.**

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
1 Week to 90 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patient undergoing eye examination

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Amblyopia Risk Factor (refractive error and/or strabismus)

Time Frame: 2 hours or less: Screening and Gold Standard Exam performed the same day, usually within the same hour.

Whether pre-defined, age-related risk factor is present. AAPOS has published standard levels of these refractive errors or binocular misalignment that render a child at risk of developing sight-threatening amblyopia.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Alaska Blind Child Discovery
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Performance of 2WIN Photoscreener With... | Clinical Trial